anti-AXL/anti-PD-L1 bispecific antibody drug conjugate (Celon Pharma)

N/A

Report date: 2025/06/11 11:17:48

Base Information

Drug Nameanti-AXL/anti-PD-L1 bispecific antibody drug conjugate (Celon Pharma)

Drug Alias NameCPBT-0976-MMAECPL-976-MMAE

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)Biologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized

Mechanisms of ActionAXL receptor tyrosine kinase modulatorsProgrammed death-ligand 1 modulatorsMicrotubule inhibitors

TargetsAXL receptor tyrosine kinaseProgrammed death-ligand 1

Therapy Area/IndicationsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryPoland

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesCelon Pharma SP

China Registration ClassN/A

Develop Information

Active CompaniesCelon Pharma SP

Inactive CompaniesN/A

Active IndicationsBreast Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A